SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
(a) SHORT TITLE.—This Act may be cited as the 
‘‘SUPPORT for Patients and Communities Reauthoriza-
tion Act of 2025’’. 
(b) TABLE OF CONTENTS.—The table of contents for 
this Act is as follows: 
Sec. 1. Short title; table of contents. 
TITLE I—PREVENTION 
Sec. 101. Prenatal and postnatal health. 
Sec. 102. Monitoring and education regarding infections associated with illicit 
drug use and other risk factors. 
Sec. 103. Preventing overdoses of controlled substances. 
Sec. 104. Support for individuals and families impacted by fetal alcohol spec-
trum disorder. 
Sec. 105. Promoting state choice in PDMP systems. 
Sec. 106. First responder training program. 
Sec. 107. Donald J. Cohen National Child Traumatic Stress Initiative. 
Sec. 108. Protecting suicide prevention lifeline from cybersecurity incidents. 
Sec. 109. Monitoring and reporting of child, youth, and adult trauma. 
Sec. 110. Bruce’s law. 
Sec. 111. Guidance on at-home drug disposal systems. 
Sec. 112. Assessment of opioid drugs and actions. 
Sec. 113. Grant program for State and Tribal response to opioid use disorders. 
TITLE II—TREATMENT 
Sec. 201. Residential treatment program for pregnant and postpartum women. 
Sec. 202. Improving access to addiction medicine providers. 
Sec. 203. Mental and behavioral health education and training grants. 
Sec. 204. Loan repayment program for substance use disorder treatment work-
force. 
Sec. 205. Development and dissemination of model training programs for sub-
stance use disorder patient records. 
Sec. 206. Task force on best practices for trauma-informed identification, refer-
ral, and support. 
Sec. 207. Grants to enhance access to substance use disorder treatment. 
Sec. 208. State guidance related to individuals with serious mental illness and 
children with serious emotional disturbance. 
Sec. 209. Reviewing the scheduling of approved products containing a combina-
tion of buprenorphine and naloxone. 
Sec. 210. References to opioid overdose reversal agents in HHS grant pro-
grams. 
Sec. 211. Roundtable on using health information technology to improve mental 
health and substance use care outcomes. 
TITLE III—RECOVERY 
Sec. 301. Building communities of recovery.
Sec. 302. Peer support technical assistance center. 
Sec. 303. Comprehensive opioid recovery centers. 
Sec. 304. Youth prevention and recovery. 
Sec. 305. CAREER Act. 
Sec. 306. Addressing economic and workforce impacts of the opioid crisis. 
Sec. 307. Review of information related to funding opportunities under pro-
grams administered by SAMHSA. 
TITLE IV—MISCELLANEOUS MATTERS 
Sec. 401. Delivery of a controlled substance by a pharmacy to a prescribing 
practitioner. 
Sec. 402. Required training for prescribers of controlled substances. 
TITLE I—PREVENTION 
SEC. 101. PRENATAL AND POSTNATAL HEALTH. 
Section 317L(d) of the Public Health Service Act (42 
U.S.C. 247b–13(d)) is amended by striking ‘‘such sums 
as may be necessary for each of the fiscal years 2019 
through 2023’’ and inserting ‘‘$4,250,000 for each of fis-
cal years 2026 through 2030’’. 
SEC. 102. MONITORING AND EDUCATION REGARDING IN-
FECTIONS ASSOCIATED WITH ILLICIT DRUG 
USE AND OTHER RISK FACTORS. 
Section 317N(d) of the Public Health Service Act (42 
U.S.C. 247b–15(d)) is amended by striking ‘‘fiscal years 
2019 through 2023’’ and inserting ‘‘fiscal years 2026 
through 2030’’. 
SEC. 103. PREVENTING OVERDOSES OF CONTROLLED SUB-
STANCES. 
(a) IN GENERAL.—Section 392A of the Public 
Health Service Act (42 U.S.C. 280b–1) is amended— 
(1) in subsection (a)(2)—
(A) in subparagraph (C), by inserting ‘‘and 
associated risks’’ before the period at the end; 
and 
(B) in subparagraph (D), by striking 
‘‘opioids’’ and inserting ‘‘substances causing 
overdose’’; and 
(2) in subsection (b)(2)— 
(A) in subparagraph (B), by inserting ‘‘, 
and associated risk factors,’’ after ‘‘such 
overdoses’’; 
(B) in subparagraph (C), by striking ‘‘cod-
ing’’ and inserting ‘‘monitoring and identi-
fying’’; 
(C) in subparagraph (E)— 
(i) by inserting a comma after ‘‘public 
health laboratories’’; and 
(ii) by inserting ‘‘and other emerging 
substances related’’ after ‘‘analogues’’; and 
(D) in subparagraph (F), by inserting 
‘‘and associated risk factors’’ after ‘‘overdoses’’. 
(b) ADDITIONAL GRANTS.—Section 392A(a)(3) of 
the Public Health Service Act (42 U.S.C. 280b–1(a)(3)) 
is amended—
(1) in the matter preceding subparagraph (A), 
by striking ‘‘and Indian Tribes—’’ and inserting 
‘‘and Indian Tribes for the following purposes:’’; 
(2) by amending subparagraph (A) to read as 
follows: 
‘‘(A) To carry out innovative projects for 
grantees to detect, identify, and rapidly respond 
to controlled substance misuse, abuse, and 
overdoses, and associated risk factors, including 
changes in patterns of such controlled sub-
stance use. Such projects may include the use 
of innovative, evidence-based strategies for de-
tecting such patterns, such as wastewater sur-
veillance, if proven to support actionable pre-
vention strategies, in a manner consistent with 
applicable Federal and State privacy laws.’’; 
and 
(3) in subparagraph (B), by striking ‘‘for any’’ 
and inserting ‘‘For any’’. 
(c) AUTHORIZATION OF APPROPRIATIONS.—Section 
392A(e) of the Public Health Service Act (42 U.S.C. 
280b–1(e)) is amended by striking ‘‘$496,000,000 for 
each of fiscal years 2019 through 2023’’ and inserting 
‘‘$505,579,000 for each of fiscal years 2026 through 
2030’’.
SEC. 104. SUPPORT FOR INDIVIDUALS AND FAMILIES IM-
PACTED BY FETAL ALCOHOL SPECTRUM DIS-
ORDER. 
(a) IN GENERAL.—Part O of title III of the Public 
Health Service Act (42 U.S.C. 280f et seq.) is amended 
to read as follows: 
‘‘PART 
O—FETAL 
ALCOHOL 
SPECTRUM 
DIS-
ORDER PREVENTION AND SERVICES PRO-
GRAM 
‘‘SEC. 399H. FETAL ALCOHOL SPECTRUM DISORDERS PRE-
VENTION, INTERVENTION, AND SERVICES DE-
LIVERY PROGRAM. 
‘‘(a) IN GENERAL.—The Secretary shall establish or 
continue activities to support a comprehensive fetal alcohol 
spectrum disorders (referred to in this section as ‘FASD’) 
education, prevention, identification, intervention, and 
services delivery program, which may include— 
‘‘(1) an education and public awareness pro-
gram to support, conduct, and evaluate the effective-
ness of— 
‘‘(A) 
educational 
programs 
targeting 
health professions schools, social and other sup-
portive services, educators and counselors and 
other service providers in all phases of child-
hood development, and other relevant service 
providers, concerning the prevention, identifica-
tion, and provision of services for infants, chil-
dren, adolescents, and adults with FASD; 
‘‘(B) strategies to educate school-age chil-
dren, including pregnant and high-risk youth, 
concerning FASD; 
‘‘(C) public and community awareness pro-
grams concerning FASD; and 
‘‘(D) strategies to coordinate information 
and services across affected community agen-
cies, including agencies providing social services 
such as foster care, adoption, and social work, 
agencies providing health services, and agencies 
involved in education, vocational training, and 
civil and criminal justice; 
‘‘(2) supporting and conducting research on 
FASD, as appropriate, including to— 
‘‘(A) develop appropriate medical diag-
nostic methods for identifying FASD; and 
‘‘(B) develop effective culturally and lin-
guistically appropriate evidence-based or evi-
dence-informed interventions and appropriate 
supports for preventing prenatal alcohol expo-
sure, which may co-occur with exposure to other 
substances;
services, that are aimed at the unique challenges fac-
ing individuals with fetal alcohol spectrum disorder 
or fetal alcohol effect and their families. 
‘‘(b) GRANTS AND TECHNICAL ASSISTANCE.— 
‘‘(1) IN GENERAL.—The Secretary may award 
grants, cooperative agreements and contracts and 
provide technical assistance to eligible entities to 
carry out subsection (a). 
‘‘(2) ELIGIBLE ENTITIES.—To be eligible to re-
ceive a grant, or enter into a cooperative agreement 
or contract, under this section, an entity shall— 
‘‘(A) be a State, Indian Tribe or Tribal or-
ganization, local government, scientific or aca-
demic institution, or nonprofit organization; 
and 
‘‘(B) prepare and submit to the Secretary 
an application at such time, in such manner, 
and containing such information as the Sec-
retary may require, including a description of 
the activities that the entity intends to carry 
out using amounts received under this section. 
‘‘(3) ADDITIONAL
APPLICATION
CONTENTS.— 
The Secretary may require that an eligible entity in-
clude in the application submitted under paragraph 
(2)(B)—
‘‘(A) a designation of an individual to 
serve as a FASD State or Tribal coordinator of 
activities such eligible entity proposes to carry 
out through a grant, cooperative agreement, or 
contract under this section; and 
‘‘(B) a description of an advisory com-
mittee the entity will establish to provide guid-
ance for the entity on developing and imple-
menting a statewide or Tribal strategic plan to 
prevent FASD and provide for the identifica-
tion, treatment, and support of individuals with 
FASD and their families. 
‘‘(c) DEFINITION OF FASD-INFORMED.—For pur-
poses of this section, the term ‘FASD-informed’, with re-
spect to support or an intervention program, means that 
such support or intervention program uses culturally and 
linguistically informed evidence-based or practice-based 
interventions and appropriate resources to support an im-
proved quality of life for an individual with FASD and 
the family of such individual. 
‘‘SEC. 399I. STRENGTHENING CAPACITY AND EDUCATION 
FOR 
FETAL 
ALCOHOL 
SPECTRUM 
DIS-
ORDERS. 
‘‘(a) IN
GENERAL.—The Secretary shall award 
grants, contracts, or cooperative agreements, as the Sec-
retary determines appropriate, to public or nonprofit pri-
vate entities with demonstrated expertise in the field of 
fetal alcohol spectrum disorders (referred to in this section 
as ‘FASD’). Such awards shall be for the purposes of 
building local, Tribal, State, and nationwide capacities to 
prevent the occurrence of FASD by carrying out the pro-
grams described in subsection (b). 
‘‘(b) PROGRAMS.—An entity receiving an award 
under subsection (a) may use such award for the following 
purposes: 
‘‘(1) Developing and supporting public edu-
cation and outreach activities to raise public aware-
ness of the risks associated with alcohol consumption 
during pregnancy. 
‘‘(2) Acting as a clearinghouse for evidence- 
based resources on FASD prevention, identification, 
and culturally and linguistically appropriate best 
practices to help inform systems of care for individ-
uals with FASD across their lifespan. 
‘‘(3) Increasing awareness and understanding 
of efficacious, evidence-based screening tools and 
culturally and linguistically appropriate evidence- 
based intervention services and best practices, which 
may include improving the capacity for State, Trib-
al, and local affiliates.
‘‘(4) Providing technical assistance to recipients 
of grants, cooperative agreements, or contracts 
under section 399H, as appropriate. 
‘‘(c) APPLICATION.—To be eligible for a grant, con-
tract, or cooperative agreement under this section, an enti-
ty shall submit to the Secretary an application at such 
time, in such manner, and containing such information as 
the Secretary may require. 
‘‘(d) SUBCONTRACTING.—A public or private non-
profit entity may carry out the following activities required 
under this section through contracts or cooperative agree-
ments with other public and private nonprofit entities with 
demonstrated expertise in FASD: 
‘‘(1) Resource development and dissemination. 
‘‘(2) Intervention services. 
‘‘(3) Training and technical assistance. 
‘‘SEC. 399J. AUTHORIZATION OF APPROPRIATIONS. 
‘‘There are authorized to be appropriated to carry out 
this part $12,500,000 for each of fiscal years 2026 
through 2030.’’. 
(b) REPORT.—Not later than 4 years after the date 
of enactment of this Act, and every year thereafter, the 
Secretary of Health and Human Services shall prepare 
and submit to the Committee on Health, Education, 
Labor, and Pensions of the Senate and the Committee on
Energy and Commerce of the House of Representatives 
a report containing— 
(1) a review of the activities carried out pursu-
ant to sections 399H and 399I of the Public Health 
Service Act, as amended, to advance public edu-
cation and awareness of fetal alcohol spectrum dis-
orders (referred to in this section as ‘‘FASD’’); 
(2) a description of— 
(A) the activities carried out pursuant to 
such sections 399H and 399I to identify, pre-
vent, and treat FASD; and 
(B) methods used to evaluate the outcomes 
of such activities; and 
(3) an assessment of activities carried out pur-
suant to such sections 399H and 399I to support in-
dividuals with FASD. 
SEC. 105. PROMOTING STATE CHOICE IN PDMP SYSTEMS. 
Section 399O(h) of the Public Health Service Act (42 
U.S.C. 280g–3(h)) is amended by adding at the end the 
following: 
‘‘(5) PROMOTING STATE CHOICE.—Nothing in 
this section shall be construed to authorize the Sec-
retary to require States to use a specific vendor or 
a specific interoperability connection other than to 
align with nationally recognized, consensus-based
open standards, such as in accordance with sections 
3001 and 3004.’’. 
SEC. 106. FIRST RESPONDER TRAINING PROGRAM. 
Section 546 of the Public Health Service Act (42 
U.S.C. 290ee–1) is amended— 
(1) in subsection (a), by striking ‘‘tribes and 
tribal’’ and inserting ‘‘Tribes and Tribal’’; 
(2) in subsections (a), (c), and (d)— 
(A) by striking ‘‘approved or cleared’’ each 
place it appears and inserting ‘‘approved, 
cleared, or otherwise legally marketed’’; and 
(B) by striking ‘‘opioid’’ each place it ap-
pears; 
(3) in subsection (f)— 
(A) by striking ‘‘approved or cleared’’ each 
place it appears and inserting ‘‘approved, 
cleared, or otherwise legally marketed’’; 
(B) in paragraph (1), by striking ‘‘opioid’’; 
(C) in paragraph (2)— 
(i) by striking ‘‘opioid and heroin’’ 
and inserting ‘‘opioid, heroin, and other 
drug’’; and 
(ii) by striking ‘‘opioid overdose’’ and 
inserting ‘‘overdose’’; and
(D) in paragraph (3), by striking ‘‘opioid 
and heroin’’; and 
(4) in subsection (h), by striking ‘‘$36,000,000 
for each of fiscal years 2019 through 2023’’ and in-
serting ‘‘$57,000,000 for each of fiscal years 2026 
through 2030’’. 
SEC. 107. DONALD J. COHEN NATIONAL CHILD TRAUMATIC 
STRESS INITIATIVE. 
(a) TECHNICAL AMENDMENT.—The second part G of 
title V of the Public Health Service Act (42 U.S.C. 290kk 
et seq.), as added by section 144 of the Community Re-
newal Tax Relief Act of 2000 (Public Law 106–554), is 
amended— 
(1) by redesignating such part as part J; and 
(2) by redesignating sections 581 through 584 
as sections 596 through 596C, respectively. 
(b) IN GENERAL.—Section 582 of the Public Health 
Service Act (42 U.S.C. 290hh–1) is amended— 
(1) in the section heading, by striking ‘‘VIO-
LENCE RELATED STRESS’’ and inserting ‘‘TRAU-
MATIC EVENTS’’; 
(2) in subsection (a)— 
(A) in the matter preceding paragraph (1), 
by striking ‘‘tribes and tribal’’ and inserting 
‘‘Tribes and Tribal’’; and
(B) in paragraph (2), by inserting ‘‘and 
dissemination’’ after ‘‘the development’’; 
(3) in subsection (b), by inserting ‘‘and dissemi-
nation’’ after ‘‘the development’’; 
(4) in subsection (d)— 
(A) by striking ‘‘The NCTSI’’ and insert-
ing the following: 
‘‘(1) COORDINATING
CENTER.—The NCTSI’’; 
and 
(B) by adding at the end the following: 
‘‘(2) NCTSI GRANTEES.—In carrying out sub-
section (a)(2), NCTSI grantees shall develop 
trainings and other resources, as applicable and ap-
propriate, to support implementation of the evi-
dence-based practices developed and disseminated 
under such subsection.’’; 
(5) in subsection (e)— 
(A) by redesignating paragraphs (1) and 
(2) as subparagraphs (A) and (B), respectively, 
and adjusting the margins accordingly; 
(B) in subparagraph (A), as so redesig-
nated, by inserting ‘‘and implementation’’ after 
‘‘the dissemination’’; 
(C) by striking ‘‘The NCTSI’’ and insert-
ing the following:
‘‘(1) COORDINATING
CENTER.—The NCTSI’’; 
and 
(D) by adding at the end the following: 
‘‘(2) NCTSI 
GRANTEES.—NCTSI grantees 
shall, as appropriate, collaborate with other such 
grantees, the NCTSI coordinating center, and the 
Secretary in carrying out subsections (a)(2) and 
(d)(2).’’; 
(6) by amending subsection (h) to read as fol-
lows: 
‘‘(h) APPLICATION AND EVALUATION.—To be eligible 
to receive a grant, contract, or cooperative agreement 
under subsection (a), a public or nonprofit private entity 
or an Indian Tribe or Tribal organization shall submit to 
the Secretary an application at such time, in such manner, 
and containing such information and assurances as the 
Secretary may require, including— 
‘‘(1) a plan for the evaluation of the activities 
funded under the grant, contract, or agreement, in-
cluding both process and outcomes evaluation, and 
the submission of an evaluation at the end of the 
project period; and 
‘‘(2) a description of how such entity, Indian 
Tribe, or Tribal organization will support efforts led 
by the Secretary or the NCTSI coordinating center,
as applicable, to evaluate activities carried out under 
this section.’’; and 
(7) by amending subsection (j) to read as fol-
lows: 
‘‘(j) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section— 
‘‘(1) $98,887,000 for fiscal year 2026; 
‘‘(2) $98,887,000 for fiscal year 2027; 
‘‘(3) $98,887,000 for fiscal year 2028; 
‘‘(4) $100,000,000 for fiscal year 2029; and 
‘‘(5) $100,000,000 for fiscal year 2030.’’. 
SEC. 108. PROTECTING SUICIDE PREVENTION LIFELINE 
FROM CYBERSECURITY INCIDENTS. 
(a) NATIONAL SUICIDE PREVENTION LIFELINE PRO-
GRAM.—Section 520E–3(b) of the Public Health Service 
Act (42 U.S.C. 290bb–36c(b)) is amended— 
(1) in paragraph (4), by striking ‘‘and’’ at the 
end; 
(2) in paragraph (5), by striking the period at 
the end and inserting ‘‘; and’’; and 
(3) by adding at the end the following: 
‘‘(6) taking such steps as may be necessary to 
ensure the suicide prevention hotline is protected 
from cybersecurity incidents and eliminates known 
cybersecurity vulnerabilities.’’.
(b) REPORTING.—Section 520E–3 of the Public 
Health Service Act (42 U.S.C. 290bb–36c) is amended— 
(1) by redesignating subsection (f) as sub-
section (g); and 
(2) by inserting after subsection (e) the fol-
lowing: 
‘‘(f) CYBERSECURITY REPORTING.— 
‘‘(1) NOTIFICATION.— 
‘‘(A) IN
GENERAL.—The program’s net-
work administrator receiving Federal funding 
pursuant to subsection (a) shall report to the 
Assistant Secretary, in a manner that protects 
personal privacy, consistent with applicable 
Federal and State privacy laws— 
‘‘(i) 
any 
identified 
cybersecurity 
vulnerabilities to the program within a rea-
sonable amount of time after identification 
of such a vulnerability; and 
‘‘(ii) any identified cybersecurity inci-
dents to the program within a reasonable 
amount of time after identification of such 
incident. 
‘‘(B) LOCAL AND REGIONAL CRISIS CEN-
TERS.—Local and regional crisis centers par-
ticipating in the program shall report to the
program’s network administrator identified 
under subparagraph (A), in a manner that pro-
tects personal privacy, consistent with applica-
ble Federal and State privacy laws— 
‘‘(i) 
any 
identified 
cybersecurity 
vulnerabilities to the program within a rea-
sonable amount of time after identification 
of such vulnerability; and 
‘‘(ii) any identified cybersecurity inci-
dents to the program within a reasonable 
amount of time after identification of such 
incident. 
‘‘(2) NOTIFICATION.—If the program’s network 
administrator receiving funding pursuant to sub-
section (a) discovers, or is informed by a local or re-
gional crisis center pursuant to paragraph (1)(B) of, 
a cybersecurity vulnerability or incident, within a 
reasonable amount of time after such discovery or 
receipt of information, such entity shall report the 
vulnerability or incident to the Assistant Secretary. 
‘‘(3) CLARIFICATION.— 
‘‘(A) OVERSIGHT.— 
‘‘(i) LOCAL
AND
REGIONAL
CRISIS 
CENTERS.—Except as provided in clause 
(ii), local and regional crisis centers par-
(1) conduct and complete a study that evaluates 
cybersecurity risks and vulnerabilities associated 
with the 9–8–8 National Suicide Prevention Lifeline; 
and 
(2) submit a report on the findings of such 
study to the Committee on Health, Education, 
Labor, and Pensions of the Senate and the Com-
mittee on Energy and Commerce of the House of 
Representatives. 
SEC. 109. MONITORING AND REPORTING OF CHILD, YOUTH, 
AND ADULT TRAUMA. 
Section 7131(e) of the SUPPORT for Patients and 
Communities Act (42 U.S.C. 242t(e)) is amended by strik-
ing ‘‘$2,000,000 for each of fiscal years 2019 through 
2023’’ and inserting ‘‘$9,000,000 for each of fiscal years 
2026 through 2030’’. 
SEC. 110. BRUCE’S LAW. 
(a) YOUTH PREVENTION AND RECOVERY.—Section 
7102(c) of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 290bb–7a(c)) is amended— 
(1) in paragraph (3)(A)(i), by inserting ‘‘, 
which may include strategies to increase education 
and awareness of the potency and dangers of syn-
thetic opioids (including drugs contaminated with
fentanyl) and, as appropriate, other emerging drug 
use or misuse issues’’ before the semicolon; and 
(2) in paragraph (4)(A), by inserting ‘‘and 
strategies to increase education and awareness of 
the potency and dangers of synthetic opioids (includ-
ing drugs contaminated with fentanyl) and, as ap-
propriate, emerging drug use or misuse issues’’ be-
fore the semicolon. 
(b) INTERDEPARTMENTAL SUBSTANCE USE DIS-
ORDERS COORDINATING COMMITTEE.—Section 7022 of 
the SUPPORT for Patients and Communities Act (42 
U.S.C. 290aa note) is amended— 
(1) by striking subsection (g) and inserting the 
following: 
‘‘(g) WORKING GROUPS.— 
‘‘(1) IN GENERAL.—The Committee may estab-
lish working groups for purposes of carrying out the 
duties described in subsection (e). Any such working 
group shall be composed of members of the Com-
mittee (or the designees of such members) and may 
hold such meetings as are necessary to carry out the 
duties delegated to the working group. 
‘‘(2) 
ADDITIONAL
FEDERAL
INTERAGENCY 
WORK GROUP ON FENTANYL CONTAMINATION OF IL-
LEGAL DRUGS.—
‘‘(A) ESTABLISHMENT.—The Secretary, 
acting through the Committee, shall establish a 
Federal Interagency Work Group on Fentanyl 
Contamination of Illegal Drugs (referred to in 
this paragraph as the ‘Work Group’) consisting 
of representatives from relevant Federal depart-
ments and agencies on the Committee. 
‘‘(B) CONSULTATION.—The Work Group 
shall consult with relevant stakeholders and 
subject matter experts, including— 
‘‘(i) State, Tribal, and local subject 
matter experts in reducing, preventing, and 
responding to drug overdose caused by 
fentanyl contamination of illicit drugs; and 
‘‘(ii) family members of both adults 
and youth who have overdosed by fentanyl 
contaminated illicit drugs. 
‘‘(C) DUTIES.—The Work Group shall— 
‘‘(i) examine Federal efforts to reduce 
and prevent drug overdose by fentanyl-con-
taminated illicit drugs; 
‘‘(ii) identify strategies to improve 
State, Tribal, and local responses to over-
dose by fentanyl-contaminated illicit drugs;
‘‘(iii) coordinate with the Secretary, as 
appropriate, in carrying out activities to 
raise public awareness of synthetic opioids 
and other emerging drug use and misuse 
issues; 
‘‘(iv) make recommendations to Con-
gress for improving Federal programs, in-
cluding with respect to the coordination of 
efforts across such programs; and 
‘‘(v) make recommendations for edu-
cating youth on the potency and dangers of 
drugs contaminated by fentanyl. 
‘‘(D) ANNUAL REPORT TO SECRETARY.— 
The Work Group shall annually prepare and 
submit to the Secretary, the Committee on 
Health, Education, Labor, and Pensions of the 
Senate, and the Committee on Energy and 
Commerce and the Committee on Education 
and Workforce of the House of Representatives, 
a report on the activities carried out by the 
Work Group under subparagraph (C), including 
recommendations to reduce and prevent drug 
overdose by fentanyl contamination of illegal 
drugs, in all populations, and specifically among 
youth at risk for substance misuse.’’; and
(2) by striking subsection (i) and inserting the 
following: 
‘‘(i) SUNSET.—The Committee shall terminate on 
September 30, 2030.’’. 
SEC. 111. GUIDANCE ON AT-HOME DRUG DISPOSAL SYS-
TEMS. 
(a) IN GENERAL.—Not later than one year after the 
date of enactment of this Act, the Secretary of Health and 
Human Services, in consultation with the Administrator 
of the Drug Enforcement Administration, shall publish 
guidance to facilitate the use of at-home safe disposal sys-
tems for applicable drugs. 
(b) CONTENTS.—The guidance under subsection (a) 
shall include— 
(1) recommended standards for effective at- 
home drug disposal systems to meet applicable re-
quirements enforced by the Food and Drug Adminis-
tration; 
(2) recommended information to include as in-
structions for use to disseminate with at-home drug 
disposal systems; 
(3) best practices and educational tools to sup-
port the use of an at-home drug disposal system, as 
appropriate; and
(4) recommended use of licensed health pro-
viders for the dissemination of education, instruc-
tion, and at-home drug disposal systems, as appro-
priate. 
SEC. 112. ASSESSMENT OF OPIOID DRUGS AND ACTIONS. 
(a) IN GENERAL.—Not later than one year after the 
date of enactment of this Act, the Secretary of Health and 
Human Services (referred to in this section as the ‘‘Sec-
retary’’) shall publish on the website of the Food and 
Drug Administration (referred to in this section as the 
‘‘FDA’’) a report that outlines a plan for assessing opioid 
analgesic drugs that are approved under section 505 of 
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
355) that addresses the public health effects of such opioid 
analgesic drugs as part of the benefit-risk assessment and 
the activities of the FDA that relate to facilitating the de-
velopment of nonaddictive medical products intended to 
treat pain or addiction. Such report shall include— 
(1) an update on the actions taken by the FDA 
to consider the effectiveness, safety, benefit-risk pro-
file, and use of approved opioid analgesic drugs; 
(2) a timeline for an assessment of the potential 
need, as appropriate, for labeling changes, revised or 
additional postmarketing requirements, enforcement 
actions, or withdrawals for opioid analgesic drugs;
(3) an overview of the steps that the FDA has 
taken to support the development and approval of 
nonaddictive medical products intended to treat pain 
or addiction, and actions planned to further support 
the development and approval of such products; and 
(4) an overview of the consideration by the 
FDA of clinical trial methodologies for analgesic 
drugs, including the enriched enrollment randomized 
withdrawal methodology, and the benefits and draw-
backs associated with different trial methodologies 
for such drugs, incorporating any public input re-
ceived under subsection (b). 
(b) PUBLIC INPUT.—In carrying out subsection (a), 
the Secretary shall provide an opportunity for public input 
concerning the regulation by the FDA of opioid analgesic 
drugs, including scientific evidence that relates to condi-
tions of use, safety, or benefit-risk assessment (including 
consideration of the public health effects) of such opioid 
analgesic drugs. 
SEC. 113. GRANT PROGRAM FOR STATE AND TRIBAL RE-
SPONSE TO OPIOID USE DISORDERS. 
The activities carried out pursuant to section 
1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 
290ee–3a(b)(4)(A)) may include facilitating access to 
products used to prevent overdose deaths by detecting the
presence of one or more substances, such as fentanyl and 
xylazine test strips, to the extent the purchase and posses-
sion of such products is consistent with Federal and State 
law. 
TITLE II—TREATMENT 
SEC. 201. RESIDENTIAL TREATMENT PROGRAM FOR PREG-
NANT AND POSTPARTUM WOMEN. 
Section 508 of the Public Health Service Act (42 
U.S.C. 290bb–1) is amended— 
(1) in subsection (d)(11)(C), by striking ‘‘pro-
viding health services’’ and inserting ‘‘providing 
health care services’’; 
(2) in subsection (g)— 
(A) by inserting ‘‘a plan describing’’ after 
‘‘will provide’’; and 
(B) by adding at the end the following: 
‘‘Such plan may include a description of how 
such applicant will target outreach to women 
disproportionately impacted by maternal sub-
stance use disorder.’’; and 
(3) in subsection (s), by striking ‘‘$29,931,000 
for each of fiscal years 2019 through 2023’’ and in-
serting ‘‘$38,931,000 for each of fiscal years 2026 
through 2030’’.
SEC. 202. IMPROVING ACCESS TO ADDICTION MEDICINE 
PROVIDERS. 
Section 597 of the Public Health Service Act (42 
U.S.C. 290ll) is amended— 
(1) in subsection (a)(1), by inserting ‘‘diag-
nosis,’’ after ‘‘related to’’; and 
(2) in subsection (b), by inserting ‘‘addiction 
medicine,’’ after ‘‘psychiatry,’’. 
SEC. 203. MENTAL AND BEHAVIORAL HEALTH EDUCATION 
AND TRAINING GRANTS. 
Section 756(f) of the Public Health Service Act (42 
U.S.C. 294e–1(f)) is amended by striking ‘‘fiscal years 
2023 through 2027’’ and inserting ‘‘fiscal years 2026 
through 2030’’. 
SEC. 204. LOAN REPAYMENT PROGRAM FOR SUBSTANCE 
USE DISORDER TREATMENT WORKFORCE. 
Section 781(j) of the Public Health Service Act (42 
U.S.C. 295h(j)) is amended by striking ‘‘$25,000,000 for 
each of fiscal years 2019 through 2023’’ and inserting 
‘‘$40,000,000 for each of fiscal years 2026 through 
2030’’.
SEC. 205. DEVELOPMENT AND DISSEMINATION OF MODEL 
TRAINING PROGRAMS FOR SUBSTANCE USE 
DISORDER PATIENT RECORDS. 
Section 7053 of the SUPPORT for Patients and 
Communities Act (42 U.S.C. 290dd–2 note) is amended 
by striking subsection (e). 
SEC. 206. TASK FORCE ON BEST PRACTICES FOR TRAUMA- 
INFORMED IDENTIFICATION, REFERRAL, AND 
SUPPORT. 
Section 7132 of the SUPPORT for Patients and 
Communities Act (Public Law 115–271; 132 Stat. 4046) 
is amended— 
(1) in subsection (b)(1)— 
(A) by redesignating subparagraph (CC) as 
subparagraph (DD); and 
(B) by inserting after subparagraph (BB) 
the following: 
‘‘(CC) The Administration for Community 
Living.’’; 
(2) in subsection (d)(1), in the matter pre-
ceding subparagraph (A), by inserting ‘‘, develop-
mental disability service providers’’ before ‘‘, individ-
uals who are’’; and 
(3) in subsection (i), by striking ‘‘2023’’ and in-
serting ‘‘2030’’.
SEC. 207. GRANTS TO ENHANCE ACCESS TO SUBSTANCE 
USE DISORDER TREATMENT. 
Section 3203 of the SUPPORT for Patients and 
Communities Act (21 U.S.C. 823 note) is amended— 
(1) by striking subsection (b); and 
(2) by striking ‘‘(a) IN GENERAL.—The Sec-
retary’’ and inserting the following: ‘‘The Sec-
retary’’. 
SEC. 208. STATE GUIDANCE RELATED TO INDIVIDUALS 
WITH SERIOUS MENTAL ILLNESS AND CHIL-
DREN WITH SERIOUS EMOTIONAL DISTURB-
ANCE. 
(a) REVIEW OF USE OF CERTAIN FUNDING.—Not 
later than 1 year after the date of enactment of this Act, 
the Secretary of Health and Human Services (referred to 
in this section as the ‘‘Secretary’’), acting through the As-
sistant Secretary for Mental Health and Substance Use, 
shall conduct a review of State use of funds made available 
under the Community Mental Health Services Block 
Grant program under subpart I of part B of title XIX 
of the Public Health Service Act (42 U.S.C. 300x et seq.) 
(referred to in this section as the ‘‘block grant program’’) 
for first episode psychosis activities. Such review shall con-
sider the following: 
(1) How States use funds for evidence-based 
treatments and services according to the standard of
care for individuals with early serious mental illness 
and children with a serious emotional disturbance. 
(2) The percentages of the State funding under 
the block grant program expended on early serious 
mental illness and first episode psychosis, and the 
number of individuals served under such funds. 
(b) REPORT AND GUIDANCE.— 
(1) REPORT.—Not later than 180 days after 
the completion of the review under subsection (a), 
the Secretary shall submit to the Committee on 
Health, Education, Labor, and Pensions and the 
Committee on Appropriations of the Senate and the 
Committee on Energy and Commerce and the Com-
mittee on Appropriations of the House of Represent-
atives a report describing— 
(A) the findings of the review under sub-
section (a); and 
(B) any recommendations for changes to 
the block grant program that would facilitate 
improved outcomes for individuals with serious 
mental illness and children with serious emo-
tional disturbance. 
(2) GUIDANCE.—Not later than 1 year after 
the date on which the report is submitted under 
paragraph (1), the Secretary shall update the guid-
ance provided to States under the block grant pro-
gram on coordinated specialty care and other evi-
dence-based mental health care services for individ-
uals with serious mental illness and children with a 
serious emotional disturbance, based on the findings 
and recommendations of such report. 
SEC. 209. REVIEWING THE SCHEDULING OF APPROVED 
PRODUCTS CONTAINING A COMBINATION OF 
BUPRENORPHINE AND NALOXONE. 
(a) SECRETARY OF HHS.—The Secretary of Health 
and Human Services shall, consistent with the require-
ments and procedures set forth in sections 201 and 202 
of the Controlled Substances Act (21 U.S.C. 811, 812)— 
(1) review the relevant data pertaining to the 
scheduling of products containing a combination of 
buprenorphine and naloxone that have been ap-
proved under section 505 of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 355); and 
(2) if appropriate, request that the Attorney 
General initiate rulemaking proceedings to revise the 
schedules accordingly with respect to such products. 
(b) ATTORNEY GENERAL.—The Attorney General 
shall review any request made by the Secretary of Health 
and Human Services under subsection (a)(2) and deter-
mine whether to initiate proceedings to revise the sched-
ules in accordance with the criteria set forth in sections 
201 and 202 of the Controlled Substances Act (21 U.S.C. 
811, 812). 
SEC. 210. REFERENCES TO OPIOID OVERDOSE REVERSAL 
AGENTS IN HHS GRANT PROGRAMS. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services shall ensure that, as appropriate, when-
ever the Department of Health and Human Services 
issues a regulation or guidance for any grant program ad-
dressing opioid misuse and use disorders, any reference 
to an opioid overdose reversal drug (such as a reference 
to naloxone) is inclusive of any opioid overdose reversal 
drug that has been approved under section 505 of the Fed-
eral Food, Drug, and Cosmetic Act (21 U.S.C. 355) for 
emergency treatment of a known or suspected opioid over-
dose. 
(b) EXISTING REFERENCES.— 
(1) UPDATE.—Not later than one year after the 
date of enactment of this Act, the Secretary of 
Health and Human Services shall update all ref-
erences described in paragraph (2) to be inclusive of 
any opioid overdose reversal drug that has been ap-
proved or otherwise authorized for use by the Food 
and Drug Administration.
(2) REFERENCES.—A reference described in 
this paragraph is any reference to an opioid overdose 
reversal drug (such as naloxone) in any regulation or 
guidance of the Department of Health and Human 
Services that— 
(A) was issued before the date of enact-
ment of this Act; and 
(B) is included in— 
(i) the grant program for State and 
Tribal response to opioid use disorders 
under section 1003 of the 21st Century 
Cures Act (42 U.S.C. 290ee–3 note) (com-
monly referred to as ‘‘State Opioid Re-
sponse Grants’’ and ‘‘Tribal Opioid Re-
sponse Grants’’); or 
(ii) the grant program for priority 
substance use disorder prevention needs of 
regional and national significance under 
section 516 of the Public Health Service 
Act (42 U.S.C. 290bb–22). 
SEC. 211. ROUNDTABLE ON USING HEALTH INFORMATION 
TECHNOLOGY TO IMPROVE MENTAL HEALTH 
AND SUBSTANCE USE CARE OUTCOMES. 
(a) ROUNDTABLE.—Not later than 180 days after 
the date of enactment of this Act, the National Coordi-
nator for Health Information Technology shall convene a 
public roundtable to examine— 
(1) how the expanded use of electronic health 
records among mental health and substance use 
service providers can improve outcomes for patients 
in mental health and substance use settings; and 
(2) how best to increase electronic health record 
adoption among such providers. 
(b) PARTICIPANTS.—The National Coordinator for 
Health Information Technology shall ensure that the par-
ticipants in the roundtable under subsection (a) include 
private and public sector stakeholders, including patients, 
providers (including providers of inpatient services and 
providers of outpatient services), and representatives of 
payors, health information exchanges, professional asso-
ciations, health information technology vendors, health in-
formation technology certification organizations, and 
State and Federal agencies. 
(c) REPORT.—Not later than 180 days after the con-
clusion of the public stakeholder roundtable under sub-
section (a), the National Coordinator for Health Informa-
tion Technology shall submit to the Committee on Health, 
Education, Labor, and Pensions of the Senate and the 
Committee on Energy and Commerce of the House of 
Representatives a report outlining information gathered
from the roundtable under subsection (a). Such report 
shall include an examination of— 
(1) recommendations from the roundtable par-
ticipants; 
(2) unique considerations for using electronic 
health record systems in mental health and sub-
stance use treatment settings; 
(3) unique considerations for developers of 
health information technology relating to certifi-
cation of electronic health record systems for use in 
mental health and substance use treatment settings 
where the applicable health information technology 
is not subject to certification requirements; 
(4) current usage of electronic health record 
systems by mental health and substance use disorder 
service providers, and the scope and magnitude of 
such providers that do not use electronic health 
record systems; 
(5) examples of how electronic health record 
systems enable coordinated care and care manage-
ment; 
(6) how electronic health record systems ad-
vance appropriate patient and provider access to se-
cure, usable electronic information exchange;
(7) how electronic health record systems can be 
connected to or support existing systems, which may 
include the 9–8–8 National Suicide Prevention Life-
line, mobile crisis response systems, and co-re-
sponder programs, to facilitate connectivity, re-
sponse, and integrated care; 
(8) any existing programs to support greater 
adoption of electronic health record systems among 
mental health and substance use service providers; 
(9) any limitations to greater adoption of elec-
tronic health record systems among mental health 
and substance use service providers; 
(10) the costs of adoption of electronic health 
record systems by mental health and substance use 
disorder service providers; and 
(11) best practices implemented by States and 
other entities to support adoption of use of elec-
tronic health records among mental health and sub-
stance use disorder service providers. 
TITLE III—RECOVERY 
SEC. 301. BUILDING COMMUNITIES OF RECOVERY. 
Section 547(f) of the Public Health Service Act (42 
U.S.C. 290ee–2(f)) is amended by striking ‘‘$5,000,000 
for each of fiscal years 2019 through 2023’’ and inserting
‘‘$17,000,000 for each of fiscal years 2026 through 
2030’’. 
SEC. 302. PEER SUPPORT TECHNICAL ASSISTANCE CEN-
TER. 
Section 547A of the Public Health Service Act (42 
U.S.C. 290ee–2a) is amended— 
(1) in subsection (b)(4), by striking ‘‘building; 
and’’ and inserting the following: ‘‘building, such 
as— 
‘‘(A) professional development of peer sup-
port specialists; and 
‘‘(B) making recovery support services 
available in nonclinical settings; and’’; 
(2) by redesignating subsections (d) and (e) as 
subsections (e) and (f), respectively; 
(3) by inserting after subsection (c) the fol-
lowing: 
‘‘(d) REGIONAL CENTERS.— 
‘‘(1) IN GENERAL.—The Secretary may estab-
lish one regional technical assistance center (referred 
to in this subsection as the ‘Regional Center’), with 
existing resources, to assist the Center in carrying 
out activities described in subsection (b) within the 
geographic region of such Regional Center in a man-
ner that is tailored to the needs of such region.
‘‘(2) EVALUATION.—Not later than 4 years 
after the date of enactment of the SUPPORT for 
Patients and Communities Reauthorization Act of 
2025, the Secretary shall evaluate the activities of 
the Regional Center and submit to the Committee 
on Health, Education, Labor, and Pensions of the 
Senate and the Committee on Energy and Com-
merce of the House of Representatives a report on 
the findings of such evaluation, including— 
‘‘(A) a description of the distinct roles and 
responsibilities of the Regional Center and the 
Center; 
‘‘(B) available information relating to the 
outcomes of the Regional Center under this 
subsection, such as any impact on the oper-
ations and efficiency of the Center relating to 
requests for technical assistance and support 
within the region of such Regional Center; 
‘‘(C) a description of any gaps or areas of 
duplication relating to the activities of the Re-
gional Center and the Center within such re-
gion; and 
‘‘(D) recommendations relating to the 
modification, expansion, or termination of the 
Regional Center under this subsection.
‘‘(3) TERMINATION.—This subsection shall ter-
minate on September 30, 2030.’’; and 
(4) in subsection (f), as so redesignated, by 
striking ‘‘$1,000,000 for each of fiscal years 2019 
through 2023’’ and inserting ‘‘$2,000,000 for each 
of fiscal years 2026 through 2030’’. 
SEC. 303. COMPREHENSIVE OPIOID RECOVERY CENTERS. 
Section 552 of the Public Health Service Act (42 
U.S.C. 290ee–7) is amended— 
(1) in subsection (d)(2)— 
(A) in the matter preceding subparagraph 
(A), by striking ‘‘and in such manner’’ and in-
serting ‘‘, in such manner, and containing such 
information and assurances, including relevant 
documentation,’’; and 
(B) in subparagraph (A), by striking ‘‘is 
capable of coordinating with other entities to 
carry out’’ and inserting ‘‘has the demonstrated 
capability to carry out, through referral or con-
tractual arrangements’’; 
(2) in subsection (h)— 
(A) 
by 
redesignating 
paragraphs 
(1) 
through (4) as subparagraphs (A) through (D), 
respectively, and adjusting the margins accord-
ingly;
(B) by striking ‘‘With respect to’’ and in-
serting the following: 
‘‘(1) IN GENERAL.—With respect to’’; and 
(C) by adding at the end the following: 
‘‘(2) ADDITIONAL REPORTING FOR CERTAIN EL-
IGIBLE ENTITIES.—An entity carrying out activities 
described in subsection (g) through referral or con-
tractual arrangements shall include in the submis-
sions required under paragraph (1) information re-
lated to the status of such referrals or contractual 
arrangements, including an assessment of whether 
such referrals or contractual arrangements are sup-
porting the ability of such entity to carry out such 
activities.’’; and 
(3) in subsection (j), by striking ‘‘2019 through 
2023’’ and inserting ‘‘2026 through 2030’’. 
SEC. 304. YOUTH PREVENTION AND RECOVERY. 
Section 7102(c) of the SUPPORT for Patients and 
Communities Act (42 U.S.C. 290bb–7a(c)) (as amended 
by section 110(a)) is amended— 
(1) in paragraph (2)— 
(A) in subparagraph (A)— 
(i) in clause (i)— 
(I) by inserting ‘‘, or a consor-
tium of local educational agencies,’’
after ‘‘a local educational agency’’; 
and 
(II) by striking ‘‘high schools’’ 
and inserting ‘‘secondary schools’’; 
and 
(ii) in clause (vi), by striking ‘‘tribe, 
or tribal’’ and inserting ‘‘Tribe, or Tribal’’; 
(B) by amending subparagraph (E) to read 
as follows: 
‘‘(E) INDIAN
TRIBE; TRIBAL
ORGANIZA-
TION.—The terms ‘Indian Tribe’ and ‘Tribal 
organization’ have the meanings given such 
terms in section 4 of the Indian Self-Deter-
mination and Education Assistance Act (25 
U.S.C. 5304).’’; 
(C) by redesignating subparagraph (K) as 
subparagraph (L); and 
(D) by inserting after subparagraph (J) 
the following: 
‘‘(K) SECONDARY
SCHOOL.—The term 
‘secondary school’ has the meaning given such 
term in section 8101 of the Elementary and 
Secondary Education Act of 1965 (20 U.S.C. 
7801).’’;
(2) in paragraph (3)(A), in the matter pre-
ceding clause (i)— 
(A) by striking ‘‘and abuse’’; and 
(B) by inserting ‘‘at increased risk for sub-
stance misuse’’ after ‘‘specific populations’’; 
(3) in paragraph (4)— 
(A) in the matter preceding subparagraph 
(A), by striking ‘‘Indian tribes’’ and inserting 
‘‘Indian Tribes’’; 
(B) in subparagraph (A), by striking ‘‘and 
abuse’’; and 
(C) in subparagraph (B), by striking ‘‘peer 
mentoring’’ and inserting ‘‘peer-to-peer sup-
port’’; 
(4) in paragraph (5), by striking ‘‘tribal’’ and 
inserting ‘‘Tribal’’; 
(5) in paragraph (6)(A)— 
(A) in clause (iv), by striking ‘‘; and’’ and 
inserting a semicolon; and 
(B) by adding at the end the following: 
‘‘(vi) a plan to sustain the activities 
carried out under the grant program, after 
the grant program has ended; and’’; 
(6) in paragraph (8), by striking ‘‘2022’’ and 
inserting ‘‘2028’’; and
(7) by amending paragraph (9) to read as fol-
lows: 
‘‘(9) AUTHORIZATION
OF
APPROPRIATIONS.— 
To carry out this subsection, there are authorized to 
be appropriated— 
‘‘(A) $10,000,000 for fiscal year 2026; 
‘‘(B) $12,000,000 for fiscal year 2027; 
‘‘(C) $13,000,000 for fiscal year 2028; 
‘‘(D) $14,000,000 for fiscal year 2029; 
and 
‘‘(E) $15,000,000 for fiscal year 2030.’’. 
SEC. 305. CAREER ACT. 
(a) IN GENERAL.—Section 7183 of the SUPPORT 
for Patients and Communities Act (42 U.S.C. 290ee–8) 
is amended— 
(1) in the section heading, by inserting ‘‘; 
TREATMENT, 
RECOVERY, 
AND
WORKFORCE 
SUPPORT GRANTS’’ after ‘‘CAREER ACT’’; 
(2) in subsection (b), by inserting ‘‘each’’ before 
‘‘for a period’’; 
(3) in subsection (c)— 
(A) in paragraph (1), by striking ‘‘the 
rates described in paragraph (2)’’ and inserting 
‘‘the average rates for calendar years 2018 
through 2022 described in paragraph (2)’’; and
(B) by amending paragraph (2) to read as 
follows: 
‘‘(2) RATES.—The rates described in this para-
graph are the following: 
‘‘(A) The highest age-adjusted average 
rates of drug overdose deaths for calendar years 
2018 through 2022 based on data from the 
Centers for Disease Control and Prevention, in-
cluding, if necessary, provisional data for cal-
endar year 2022. 
‘‘(B) The highest average rates of unem-
ployment for calendar years 2018 through 2022 
based on data provided by the Bureau of Labor 
Statistics. 
‘‘(C) The lowest average labor force par-
ticipation rates for calendar years 2018 through 
2022 based on data provided by the Bureau of 
Labor Statistics.’’; 
(4) in subsection (g)— 
(A) in each of paragraphs (1) and (3), by 
redesignating subparagraphs (A) and (B) as 
clauses (i) and (ii), respectively, and adjusting 
the margins accordingly; 
(B) 
by 
redesignating 
paragraphs 
(1) 
through (3) as subparagraphs (A) through (C),
respectively, and adjusting the margins accord-
ingly; 
(C) in the matter preceding subparagraph 
(A) (as so redesignated), by striking ‘‘An enti-
ty’’ and inserting the following: 
‘‘(1) IN GENERAL.—An entity’’; and 
(D) by adding at the end the following: 
‘‘(2) TRANSPORTATION
SERVICES.—An entity 
receiving a grant under this section may use not 
more than 5 percent of the funds for providing 
transportation for individuals to participate in an ac-
tivity supported by a grant under this section, which 
transportation shall be to or from a place of work 
or a place where the individual is receiving voca-
tional education or job training services or receiving 
services directly linked to treatment of or recovery 
from a substance use disorder. 
‘‘(3) LIMITATION.—The Secretary may not re-
quire an entity to, or give priority to an entity that 
plans to, use the funds of a grant under this section 
for activities that are not specified in this sub-
section.’’; 
(5) in subsection (i)(2), by inserting ‘‘, which 
shall include employment and earnings outcomes de-
scribed in subclauses (I) and (III) of section
116(b)(2)(A)(i) of the Workforce Innovation and 
Opportunity Act (29 U.S.C. 3141(b)(2)(A)(i)) with 
respect to the participation of such individuals with 
a substance use disorder in programs and activities 
funded by the grant under this section’’ after ‘‘sub-
section (g)’’; 
(6) in subsection (j)— 
(A) in paragraph (1), by inserting ‘‘for 
grants awarded prior to the date of enactment 
of the SUPPORT for Patients and Commu-
nities Reauthorization Act of 2025’’ after 
‘‘grant period under this section’’; and 
(B) in paragraph (2)— 
(i) in the matter preceding subpara-
graph (A), by striking ‘‘2 years after sub-
mitting the preliminary report required 
under paragraph (1)’’ and inserting ‘‘Sep-
tember 30, 2030’’; and 
(ii) in subparagraph (A), by striking 
‘‘(g)(3)’’ and inserting ‘‘(g)(1)(C)’’; and 
(7) in subsection (k), by striking ‘‘$5,000,000 
for each of fiscal years 2019 through 2023’’ and in-
serting ‘‘$12,000,000 for each of fiscal years 2026 
through 2030’’.
(b) REAUTHORIZATION OF THE CAREER ACT; RE-
COVERY HOUSING PILOT PROGRAM.— 
(1) IN GENERAL.—Section 8071 of the SUP-
PORT for Patients and Communities Act (42 
U.S.C. 5301 note; Public Law 115–271) is amend-
ed— 
(A) by striking the section heading and in-
serting ‘‘CAREER ACT; RECOVERY HOUSING 
PILOT PROGRAM’’; 
(B) in subsection (a), by striking ‘‘through 
2023’’ and inserting ‘‘through 2030’’; 
(C) in subsection (b)— 
(i) in paragraph (1), by striking ‘‘not 
later than 60 days after the date of enact-
ment of this Act’’ and inserting ‘‘not later 
than 60 days after the date of enactment 
of the SUPPORT for Patients and Com-
munities Reauthorization Act of 2025’’; 
and 
(ii) in paragraph (2)(B)(i)— 
(I) in subclause (I)— 
(aa) by striking ‘‘for cal-
endar years 2013 through 2017’’; 
and
(bb) by inserting ‘‘for cal-
endar years 2018 through 2022’’ 
after ‘‘rates of unemployment’’; 
(II) in subclause (II)— 
(aa) by striking ‘‘for cal-
endar years 2013 through 2017’’; 
and 
(bb) by inserting ‘‘for cal-
endar years 2018 through 2022’’ 
after ‘‘participation rates’’; and 
(III) by striking subclause (III) 
and inserting the following: 
‘‘(III) The highest age-adjusted 
average rates of drug overdose deaths 
for calendar years 2018 through 2022 
based on data from the Centers for 
Disease Control and Prevention, in-
cluding, if necessary, provisional data 
for calendar year 2022.’’; and 
(D) in subsection (f), by striking ‘‘For the 
2-year period following the date of enactment of 
this Act, the’’ and inserting ‘‘The’’. 
(2) CONFORMING AMENDMENT.—Subtitle F of 
title VIII of the SUPPORT for Patients and Com-
munities Act (Public Law 115–271; 132 Stat. 4095)
is amended by striking the subtitle heading and in-
serting the following: ‘‘Subtitle F—CAREER 
Act; Recovery Housing Pilot Program’’ . 
(c) CLERICAL AMENDMENTS.—The table of contents 
in section 1(b) of the SUPPORT for Patients and Com-
munities Act (Public Law 115–271; 132 Stat. 3894) is 
amended— 
(1) by striking the item relating to section 7183 
and inserting the following: 
‘‘Sec. 7183. CAREER Act; treatment, recovery, and workforce support 
grants.’’; 
(2) by striking the item relating to subtitle F 
of title VIII and inserting the following: 
‘‘Subtitle F—CAREER Act; Recovery Housing Pilot Program’’; and 
(3) by striking the item relating to section 8071 
and inserting the following: 
‘‘Sec. 8071. CAREER Act; Recovery Housing Pilot Program.’’. 
SEC. 306. ADDRESSING ECONOMIC AND WORKFORCE IM-
PACTS OF THE OPIOID CRISIS. 
Section 8041(g)(1) of the SUPPORT for Patients 
and Communities Act (29 U.S.C. 3225a(g)(1)) is amended 
by striking ‘‘2023’’ and inserting ‘‘2030’’.
SEC. 307. REVIEW OF INFORMATION RELATED TO FUNDING 
OPPORTUNITIES UNDER PROGRAMS ADMIN-
ISTERED BY SAMHSA. 
(a) IN GENERAL.—Not later than one year after the 
date of enactment of this Act, the Secretary of Health and 
Human Services (referred to in this section as the ‘‘Sec-
retary’’) shall convene a public meeting for purposes of 
improving awareness of, and access to, information related 
to current and future funding opportunities under pro-
grams administered by the Substance Abuse and Mental 
Health Services Administration (in this section referred 
to as ‘‘SAMHSA funding opportunities’’). 
(b) TOPICS.—The public meeting under subsection 
(a) shall include— 
(1) opportunities to improve the utility and 
functionality of internet websites maintained by the 
Secretary that provide information related to 
SAMHSA 
funding 
opportunities, 
such 
as 
Grants.gov; 
(2) other models for displaying and dissemi-
nating information related to SAMHSA funding op-
portunities, such as interactive dashboards; and 
(3) strategies to improve the ability of entities 
to apply for SAMHSA funding opportunities, includ-
ing entities that have not traditionally applied for 
SAMHSA funding opportunities.
(c) WEBSITE IMPROVEMENTS.—The Secretary shall 
implement improvements to Grants.gov related to 
SAMHSA funding opportunities based on stakeholder 
feedback received at the public meeting under subsection 
(a), as appropriate, to the maximum extent feasible. 
(d) REPORT.—Not later than one year after the date 
on which the public meeting under subsection (a) is con-
vened, the Secretary shall submit to the Committee on 
Health, Education, Labor, and Pensions of the Senate and 
the Committee on Energy and Commerce of the House 
of Representatives a report summarizing the findings of 
such meeting, including how the Secretary has taken into 
account the feedback received through such meeting and 
implemented— 
(1) improvements to internet websites main-
tained by the Secretary that provide information re-
lated to SAMHSA funding opportunities; and 
(2) 
strategies 
to 
improve 
awareness 
of 
SAMHSA funding opportunities.
TITLE IV—MISCELLANEOUS 
MATTERS 
SEC. 401. DELIVERY OF A CONTROLLED SUBSTANCE BY A 
PHARMACY 
TO 
A 
PRESCRIBING 
PRACTI-
TIONER. 
Section 309A(a) of the Controlled Substances Act 
(21 U.S.C. 829a(a)) is amended by striking paragraph (2) 
and inserting the following: 
‘‘(2) the controlled substance is a drug in 
schedule III, IV, or V to be administered— 
‘‘(A) by injection or implantation for the 
purpose of maintenance or detoxification treat-
ment; or 
‘‘(B) subject to a risk evaluation and miti-
gation strategy pursuant to section 505–1 of 
the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 355–1) that includes elements to assure 
safe use of the drug described in subsection 
(f)(3)(E) of such section, including a require-
ment for post-administration monitoring by a 
health care provider;’’. 
SEC. 402. REQUIRED TRAINING FOR PRESCRIBERS OF CON-
TROLLED SUBSTANCES. 
(a) IN GENERAL.—Section 303 of the Controlled 
Substances Act (21 U.S.C. 823) is amended—